EFPIA - NEWSLETTER

EFPIA Newsletter 22 May 2026

body content text

Highlights

160720 Vaccines Today Communication Challenge 20 July 2016

News

news free text

09 September 2011 110909 EMA gives first paediatric use marketing authorisation

Richard Bergström discusses CHMP's first approval for a paediatrics use marketing authorisation...

11 March 2014 140311 Access to genetic resources and the Nagoya protocol

Adoption of regulation on access to genetic resources and the fair and equitable sharing...

Blog

11 August 2011 110811 Visualizing the HPV vaccine

Richard Bergström tells us about a blog, written by David McCandless, on how designed information can help us understand...

09 September 2011 110909 EMA gives first paediatric use marketing authorisation

Richard Bergström discusses CHMP's first approval for a paediatrics use marketing authorisation...

Events

15 JUN 2016

160615 EFPIA Annual Conference 2016 Brussels, Belgium

On 15 June 2016 at the Radisson Hotel

Learn more →

09 NOV 2016

EFPIA Health Collaboration Summit 2016 - A Healthier Future for Europe Brussels

A Healthier Future for Europe

Learn more →

What we are reading

mctest 21 May 2026 (test)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶